165 related articles for article (PubMed ID: 33364782)
1. Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Cervical Cancer.
Shi X; Wang J; Dai S; Qin L; Zhou J; Chen Y
Onco Targets Ther; 2020; 13():12881-12891. PubMed ID: 33364782
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer.
Ren H; Chen Z; Yang L; Xiong W; Yang H; Xu K; Zhai E; Ding L; He Y; Song X
Cancer Manag Res; 2019; 11():4917-4930. PubMed ID: 31213910
[No Abstract] [Full Text] [Related]
3. The Apolipoprotein C1 is involved in breast cancer progression via EMT and MAPK/JNK pathway.
Zhang H; Wang Y; Liu C; Li W; Zhou F; Wang X; Zheng J
Pathol Res Pract; 2022 Jan; 229():153746. PubMed ID: 34952429
[TBL] [Abstract][Full Text] [Related]
4. APOC1 promotes the progression of osteosarcoma by binding to MTCH2.
Li R; He H; He X
Exp Ther Med; 2023 Apr; 25(4):163. PubMed ID: 36911382
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro.
Su WP; Sun LN; Yang SL; Zhao H; Zeng TY; Wu WZ; Wang D
J Biochem Mol Toxicol; 2018 May; 32(7):e22158. PubMed ID: 29719090
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
Cui Y; Miao C; Hou C; Wang Z; Liu B
Front Oncol; 2020; 10():1436. PubMed ID: 32974161
[No Abstract] [Full Text] [Related]
7. Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer.
Yi J; Ren L; Wu J; Li W; Zheng X; Du G; Wang J
Ann Transl Med; 2019 Aug; 7(16):380. PubMed ID: 31555694
[TBL] [Abstract][Full Text] [Related]
8. Decreased APOC1 expression inhibited cancer progression and was associated with better prognosis and immune microenvironment in esophageal cancer.
Guo Q; Liu XL; Jiang N; Zhang WJ; Guo SW; Yang H; Ji YM; Zhou J; Guo JL; Zhang J; Liu HS
Am J Cancer Res; 2022; 12(11):4904-4929. PubMed ID: 36504892
[TBL] [Abstract][Full Text] [Related]
9. Expression of apolipoprotein C1 in clear cell renal cell carcinoma: An oncogenic gene and a prognostic marker.
Wang HJ; Ma YX; Wang AH; Jiang YS; Jiang XZ
Kaohsiung J Med Sci; 2021 May; 37(5):419-426. PubMed ID: 33305507
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein C1 stimulates the malignant process of renal cell carcinoma via the Wnt3a signaling.
Jiang H; Tang JY; Xue D; Chen YM; Wu TC; Zhuang QF; He XZ
Cancer Cell Int; 2021 Jan; 21(1):41. PubMed ID: 33430855
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein C1 promotes tumor progression in gastric cancer.
Gu Q; Zhan T; Guan X; Lai C; Lu NA; Wang G; Xu L; Gao X; Zhang J
Oncol Res; 2023; 31(3):287-297. PubMed ID: 37305389
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for lung cancer: A marker phase I trial.
Ko HL; Wang YS; Fong WL; Chi MS; Chi KH; Kao SJ
Thorac Cancer; 2014 Nov; 5(6):500-8. PubMed ID: 26767044
[TBL] [Abstract][Full Text] [Related]
13. LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway.
Hsu W; Liu L; Chen X; Zhang Y; Zhu W
Biol Res; 2019 Jun; 52(1):33. PubMed ID: 31255182
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of APOC1 Promotes Colorectal Cancer Progression and Serves as a Potential Therapeutic Target Based on Bioinformatics Analysis.
Tang W; Liu H; Li X; Ooi TC; Rajab NF; Cao H; Sharif R
J Oncol; 2023; 2023():2611105. PubMed ID: 36908705
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
16. MiR-214 inhibits cell migration, invasion and promotes the drug sensitivity in human cervical cancer by targeting FOXM1.
Wang JM; Ju BH; Pan CJ; Gu Y; Li MQ; Sun L; Xu YY; Yin LR
Am J Transl Res; 2017; 9(8):3541-3557. PubMed ID: 28861147
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Apolipoprotein C1 (APOC1) in Clear Cell Renal Cell Carcinoma and Its Prognostic Significance.
Xiao H; Xu Y
Med Sci Monit; 2021 Feb; 27():e929347. PubMed ID: 33591959
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle (NP)-mediated APOC1 silencing to inhibit MAPK/ERK and NF-κB pathway and suppress breast cancer growth and metastasis.
Liu S; Zhang F; Liang Y; Wu G; Liu R; Li X; Saw PE; Yang Z
Sci China Life Sci; 2023 Nov; 66(11):2451-2465. PubMed ID: 37668862
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Delta-like Ligand 4 enhances the radiosensitivity and inhibits migration in cervical cancer via the reversion of epithelial-mesenchymal transition.
Yang SS; Yu DY; Du YT; Wang L; Gu L; Zhang YY; Xiao M
Cancer Cell Int; 2020; 20():344. PubMed ID: 32742191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
